Enrichment of AP-1 TF motifs in the Class 2 neo-cistrome is consistent with emerging literature implicating this complex in driving therapy-emergent PCa subtypes (36), including AR-negative neuroendocrine disease (45). This evidence concerns the gene AR and posterior cortical atrophy.